š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
Background: Irritable Bowel Syndrome (IBS) is the most prevalent functiona...
Status
Completed
Location
Biruni University Faculty of Medicine Hospital
Start Date
2025-04-01
Trial ID
NCT07619573
Treatments Being Tested
Background: IBS (irritable bowel syndrome) describes chronic abdominal pain...
Status
Unknown
Location
Hadassah Medical Organization
Start Date
2015-05
Trial ID
NCT02302703
Treatments Being Tested
The aim of the study was to consider the possible role of exercise and vagu...
Status
Completed
Location
Astoria Care
Start Date
2024-06-01
Trial ID
NCT06769516
Treatments Being Tested
Most patients suffering from the irritable bowel syndrome (IBS) report that...
Status
Completed
Location
McMaster University Medical Centre
Start Date
2021-07-15
Trial ID
NCT04364750
Irritable Bowel Syndrome is a common disease to which there is no curable t...
Status
Completed
Location
Magnus Simren
Start Date
2017-01
Trial ID
NCT02970591
This research will evaluate the effect of diets on bloating/distention, ass...
Status
Recruiting
Location
University of Michigan
Start Date
2026-03-16
Trial ID
NCT07402226
IBS is a global disease, patients often because of long-term symptoms of re...
Status
Unknown
Location
YangzhouUniversity
Start Date
2016-09
Trial ID
NCT02902926
Treatments Being Tested
Recent studies have shown that FODMAPs (Fermentable Oligosaccharides, Disac...
Status
Completed
Location
Aou Federico Ii
Start Date
2016-07
Trial ID
NCT03644602
Treatments Being Tested
This study aimed to investigate the effects of FODMAP contents in enteral n...
Status
Completed
Location
Multiple Locations
Start Date
2013-10
Trial ID
NCT02353689
Treatments Being Tested
The purpose of this study is to determine the amount and timing of when cer...
Status
Completed
Location
UCLA
Start Date
2017-03-24
Trial ID
NCT03245645
Treatments Being Tested